ArticleMultiple sclerosis journal - experimental, translational and clinical

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.

Francisco Coret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.